| Website | indexpharmab.com |
| Category | BioTech |
| Phone | 46-8-508-847-30 |
| Employees |
| TOTAL | $534M |
| VENTURE FUNDING TOTAL | $534M |
| Venture Round, 1/11 Industrifonden SEB Venture Capital | kr75M |
InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.
